Joint ESH excellence centers' national meeting on renal sympathetic denervation: A Greek experts' survey

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3031006 147 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Joint ESH excellence centers' national meeting on renal sympathetic
denervation: A Greek experts' survey
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objective: The efficacy of renal sympathetic denervation (RDN) has been
affirmed by a number of recent clinical studies, despite controversies
in this field over the last five years. Therefore, it is of paramount
importance that hypertension experts debate the merits of RDN by
revealing and expressing their personal beliefs and perspectives
regarding this procedure. Methods: A cross-sectional survey was
conducted among Greek leaders of the Hypertension Excellence Centers
with the use of a closed-type questionnaire specifically designed to
elicit information and evaluate the respondent’s views and perspectives
about RDN efficacy, safety and ideal target patient population. Results:
A total of 36 participants completed the survey. Based on the results,
RDN was considered efficient (91.7%) and safe (94.5%), while the
overwhelming majority of the participants felt confident in the
long-term efficacy (88.9%) of the intervention and that it lacks
reliable predictors of blood pressure response (94.5%). Patients with
resistant (91.7%), ultra-resistant (94.4%), and uncontrolled
hypertension (80.6%) were suggested as ideal candidates for RDN.
Establishing a close co-operation between interventionalists and
hypertension experts was considered essential to ensure the efficacy
(97.2%) as well as the safety (97.3%) of the procedure. Conclusion:
The vast majority of Greek hypertension experts surveyed were convinced
of the efficacy and safety of RDN based on the preponderance of
available scientific and clinical data. Identification of the ideal
patient group remains controversial. Respondents generally agreed on the
necessity of building close collaborative relationships between
interventionalists and hypertension experts in order to improve RDN
clinical outcome. (c) 2021 Hellenic Society of Cardiology. Publishing
services by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Έτος δημοσίευσης:
2021
Συγγραφείς:
Doumas, Michael
Andreadis, Emmanouil
Andronoglou, Markos and
Davlouros, Periklis
Dimitriadis, Kyriakos
Gkaliagkousi, Eugene
and Grassos, Harris
Hatzitolios, Apostolos
Iliakis, Panagiotis
and Kalaitzidis, Rigas
Kallistratos, Emmanouil
Kasiakogias,
Alexandros
Konstantinidis, Dimitrios
Kotsis, Vasilios and
Makris, Thomas
Manolis, Athanasios
Moulias, Athanasios and
Marketou, Maria
Papadakis, Ioannis
Papadopoulos, Dimitrios and
Poulimenos, Leonidas
Sanidas, Elias
Sarafidis, Pantelis and
Savopoulos, Christos
Stergiou, George
Tatakis, Fotis and
Thomopoulos, Konstantinos
Triantafyllidi, Helen
Triantafyllou,
Areti
Vlachakos, Dimitrios
Zebekakis, Pantelis
Ziakas,
Antonios
Papademetriou, Vasilios
Tsioufi, Costas
Task Force
Greek ESH Excelle
Περιοδικό:
Ελληνική καρδιολογική επιθεώρηση
Εκδότης:
HELLENIC CARDIOLOGICAL SOC
Τόμος:
62
Αριθμός / τεύχος:
5
Σελίδες:
355-358
Λέξεις-κλειδιά:
renal denervation; hypertension; safety; efficacy; Greek hypertension
experts
Επίσημο URL (Εκδότης):
DOI:
10.1016/j.hjc.2021.04.003
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.